Dr Paul Huang leads the Molecular and Systems Oncology Team in the Division of Molecular Pathology at the Institute of Cancer Research, London.
Originally from Singapore, he received his BSc in Biotechnology from Imperial College London in 2004. He trained in Dr Forest White’s laboratory at Massachusetts Institute of Technology (MIT) where he received a PhD in Biological Engineering in 2008
See all news stories on our website that feature the work of Dr Huang and colleagues.
Dr Huang joined the ICR in 2009 as an Institute Fellow and was awarded a Sir Henry Wellcome Fellowship by the Wellcome Trust (2009-12). He was promoted to a tenure-track Career Development Faculty (2012-17) in the Division of Cancer Biology. He is currently a tenured Career Faculty (2017-present) within the Division of Molecular Pathology and holds a Cancer Research UK Career Establishment Award.
His research focuses on the use of systems biology and molecular pathology to understand drug resistance in sarcomas and lung cancer with the goal of developing biomarkers and new therapies for these diseases.
Dr Huang serves as a member of several panels including the NCRI Sarcoma Clinical Studies Group, Research Advisory Committee of Sarcoma UK and the Scientific Evaluation Committee of the European Research Area Network (ERA-NET) TRANSCAN-2 for joint translational cancer research.
Dr Huang gained the title of Reader at the ICR in 2019.